systematic_review
    2022

    Using ginseng for menopausal women's health care: A systematic review of randomized placebo-controlled trials

    Lee HW, Ang L, Lee MS

    Published in Complementary Therapies in Clinical Practice

    Methodology

    Systematic review with meta-analysis of 15 placebo-controlled RCTs of ginseng in menopausal women, six databases to April 2022, Cochrane RoB 2.0

    Key Findings

    Ginseng reduced menopausal symptoms (SMD -0.40, 95% CI -0.73 to -0.07) and hot flashes (SMD -0.34), but pooled sexual function results were null (SMD 0.31, 95% CI -0.30 to 0.92, P = 0.32). No effect on vaginal maturation index or vaginal pH.

    Conclusions

    Ginseng eases hot flashes and general menopausal symptoms but did not improve sexual function in pooled analysis.

    Limitations

    Most included trials at concern for bias; small samples; heterogeneous ginseng preparations

    Supplements Studied

    The meta-analysis of three other studies failed to show that ginseng was beneficial for sexual function (n = 491; SMD: 0.31, 95% CI: -0.30 to 0.92, P = 0.32)

    Outcomes Measured

    The meta-analysis of three other studies failed to show that ginseng was beneficial for sexual function (n = 491; SMD: 0.31, 95% CI: -0.30 to 0.92, P = 0.32)

    Study Details

    Year:2022
    Sample Size:515
    Quality Score:6/10

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.